Fang Liu

Title: Innovations of Fang Liu in Polypeptide Research

Introduction

Fang Liu is an accomplished inventor based in Livermore, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of polypeptides. His work focuses on the development of novel polypeptides that exhibit arabinofuranosidase activity.

Latest Patents

Fang Liu holds a patent for "Polypeptides having arabinofuranosidase activity and polynucleotides encoding same." This invention relates to isolated polypeptides that possess arabinofuranosidase activity, along with their catalytic domains and carbohydrate binding modules. The patent also encompasses nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides, as well as methods for producing and utilizing the polypeptides and their components. He has 1 patent to his name.

Career Highlights

Fang Liu is currently employed at Novozymes, Inc., a leading company in the field of biotechnology. His role involves extensive research and development aimed at enhancing the functionality of polypeptides for various applications.

Collaborations

Fang has collaborated with notable colleagues, including Paul Vincent Harris and Sumati Hasani, who contribute to the innovative environment at Novozymes, Inc. Their combined expertise fosters advancements in biotechnology.

Conclusion

Fang Liu's contributions to polypeptide research exemplify the innovative spirit of modern biotechnology. His patent and ongoing work at Novozymes, Inc. highlight the importance of collaboration and research in driving scientific progress.